Ignite Creation Date:
2025-12-24 @ 1:55 PM
Ignite Modification Date:
2025-12-27 @ 9:27 PM
Study NCT ID:
NCT04607395
Status:
COMPLETED
Last Update Posted:
2020-10-29
First Post:
2020-07-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pre-operative Radiograph of Deep Carious Lesions as a Predictive Tool for Pulpal Exposure
Sponsor:
Hospices Civils de Lyon
Organization:
Study Overview
Official Title:
Pre-operative Radiograph of Deep Carious Lesions as a Predictive Tool for Pulpal Exposure.
Status:
COMPLETED
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
R2
Brief Summary:
Preserving pulpal vitality is a major challenge when excavating deep caries lesions without severe symptomatology. Pulpal exposure alters success of the treatment (dropping from 93% for indirect pulp treatment with selective excavation to 11% for direct pulpotomy) and thus prognosis of dental organ and cost-effectiveness of the treatment. The preoperative x-ray is a complementary examination which allows to estimate the depth of the carious lesion. In clinical practice, it is currently difficult to accurately measure this depth on preoperative radiographs. This lack of precision leads to a decrease in the effective capacity of the operator to predict the risk of pulpal exposure. Their interpretation is considered imprecise and is not used as a diagnostic element.
The aim of this study was to determine if the use of pre-operative retroalveolar radiographs can help to predict pulpal exposure risk.
The aim of this study was to determine if the use of pre-operative retroalveolar radiographs can help to predict pulpal exposure risk.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: